{"nct_id":"NCT07185997","title":"Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations","status":"NOT_YET_RECRUITING","status_verified_date":"2025-09","start_date":"2025-12","start_date_type":"ESTIMATED","primary_completion_date":"2029-02","primary_completion_date_type":"ESTIMATED","completion_date":"2030-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AVBP"]}